Abstract
The purpose of this study was to evaluate the contribution of DNA methylation at the phospholipase A2 group VII (PLA2G7) gene, to the risk of developing brain arteriovenous malformations (BAVMs) and intracranial aneurysms (IAs) in a Han Chinese population. Seventy patients with BAVMs or IAs and 26 control subjects were recruited to evaluate PLA2G7 methylation by bisulfite pyrosequencing. CpG3 methylation at the PLA2G7 was significantly higher in BAVM patients than in the control group (Chr6,46735560, p = 0.042). Gender subgroup analysis showed that PLA2G7 CpG4 (Chr6,46735574, p = 0.033) and mean methylation (p = 0.037) levels were significantly associated with BAVM in males. However, in females, PLA2G7 methylations were much lower in IAs than in controls [CpG2 (Chr6,46735558), p = 0.030] and BAVMs [CpG2, p = 0.001; CpG4, p = 0.007; CpG6 (Chr6, 46735579), p = 0.024; mean, p = 0.013]. In addition, mean methylation of the PLA2G7 significantly correlated with apoB levels in all individuals (r = 0.288, p = 0.006), and with apoE in BAVM patients (r = 0.259, p = 0.016). The receiver operating characteristic (ROC) curve showed that PLA2G7 CpG3 methylation might be a predictor of BAVM risk in Han Chinese (area under curve (AUC) = 0.76, p = 0.008). PLA2G7 DNA methylation was significantly associated with the risk of developing BAVMs in males or IAs in females. Future studies on the PLA2G7 mechanisms should be performed on the pathogenesis of these cerebrovascular disorders.
Similar content being viewed by others
References
Achrol AS, Kim H, Pawlikowska L et al (2007) Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery 61(4):731–739; discussion 40. https://doi.org/10.1227/01.neu.0000298901.61849.a4
Acosta S, Taimour S, Gottsater A et al (2017) Lp-PLA2 activity and mass for prediction of incident abdominal aortic aneurysms: A prospective longitudinal cohort study. Atherosclerosis 262:14–18. https://doi.org/10.1016/j.atherosclerosis.2017.04.014
Barbosa Do Prado L, Han C, Oh SP et al (2019) Recent Advances in basic research for brain arteriovenous malformation. Int J Mol Sci 20(21). https://doi.org/10.3390/ijms20215324
Bilguvar K, Yasuno K, Niemela M et al (2008) Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 40(12):1472–1477. https://doi.org/10.1038/ng.240
Can A, Gross BA, Du R (2017) The natural history of cerebral arteriovenous malformations. Handb Clin Neurol 143:15–24. https://doi.org/10.1016/B978-0-444-63640-9.00002-3
Casas JP, Ninio E, Panayiotou A et al (2010) PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry. Circulation 121(21):2284–2293. https://doi.org/10.1161/circulationaha.109.923383
Chang L, Wang Y, Ji H et al (2014) Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer’s disease. PLoS One 9(11):e110773. https://doi.org/10.1371/journal.pone.0110773
Chen X, Liu Y, Zhou S et al (2019) Methylation of the CDKN2A gene increases the risk of brain arteriovenous malformations. J Mol Neurosci 69(2):316–323. https://doi.org/10.1007/s12031-019-01360-6
Cojocaru M, Cojocaru IM, Silosi I (2010) Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases. Maedica 5(1):51–55
Contois JH, McConnell JP, Sethi AA et al (2009) Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 55(3):407–419. https://doi.org/10.1373/clinchem.2008.118356
Deng Y, Chen D, Gao F et al (2020) Silencing of long non-coding RNA GAS5 suppresses neuron cell apoptosis and nerve injury in ischemic stroke through inhibiting DNMT3B-dependent MAP 4K4 methylation. Transl Stroke Res. https://doi.org/10.1007/s12975-019-00770-3
Dotson AL, Wang J, Chen Y et al (2016) Sex differences and the role of PPAR alpha in experimental stroke. Metab Brain Dis 31(3):539–547. https://doi.org/10.1007/s11011-015-9766-x
D'Souza S (2015) Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 27(3):222–240. https://doi.org/10.1097/ANA.0000000000000130
Grallert H, Dupuis J, Bis JC et al (2012) Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J 33(2):238–251. https://doi.org/10.1093/eurheartj/ehr372
Gungor Z, Anuurad E, Enkhmaa B et al (2012) Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. Atherosclerosis 223(1):230–234. https://doi.org/10.1016/j.atherosclerosis.2012.04.021
Hakkinen T, Luoma JS, Hiltunen MO et al (1999) Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 19(12):2909–2917
Han L, Zhong C, Bu X et al (2017) Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke. Atherosclerosis 266:1–7. https://doi.org/10.1016/j.atherosclerosis.2017.09.013
Hiltunen MO, Turunen MP, Hakkinen TP et al (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 7(1):5–11. https://doi.org/10.1191/1358863x02vm418oa
Hong T, Yan Y, Li J et al (2019) High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain J Neurol 142(1):23–34. https://doi.org/10.1093/brain/awy307
Jiang D, Zheng D, Wang L et al (2013) Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One 8(3):e59752. https://doi.org/10.1371/journal.pone.0059752
Jiang D, Wang Y, Shen Y et al (2016) Estrogen and promoter methylation in the regulation of PLA2G7 transcription. Gene 591(1):262–267. https://doi.org/10.1016/j.gene.2016.07.048
Kakimoto A, Ito S, Okada H et al (2016) Age-related sex-specific changes in brain metabolism and morphology. J Nucl Med 57(2):221–225. https://doi.org/10.2967/jnumed.115.166439
Kanematsu Y, Kanematsu M, Kurihara C et al (2011) Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 42(1):173–178. https://doi.org/10.1161/strokeaha.110.590976
Katan M, Moon YP, Paik MC et al (2014) Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study. PLoS One 9(1):e83393. https://doi.org/10.1371/journal.pone.0083393
Keedy A (2006) An overview of intracranial aneurysms. McGill J Med 9(2):141–146
Kim H, Marchuk DA, Pawlikowska L, Chen Y, Su H, Yang GY, Young WL (2008) Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl 105:199–206
Low SK, Zembutsu H, Takahashi A et al (2011) Impact of LIMK1, MMP2 and TNF-alpha variations for intracranial aneurysm in Japanese population. J Hum Genet 56(3):211–216. https://doi.org/10.1038/jhg.2010.169
Ma L, Guo Y, Zhao YL et al (2015) The role of macrophage in the pathogenesis of brain arteriovenous malformation. Int J Hematol Res 1(2):52–56. https://doi.org/10.17554/j.issn.2409-3548.2015.01.12
Osbun JW, Reynolds MR, Barrow DL (2017) Arteriovenous malformations: epidemiology, clinical presentation, and diagnostic evaluation. Handb Clin Neurol 143:25–29. https://doi.org/10.1016/b978-0-444-63640-9.00003-5
Pathak S, Miller J, Morris EC et al (2018) DNA methylation of the BRD2 promoter is associated with juvenile myoclonic epilepsy in Caucasians. Epilepsia 59(5):1011–1019. https://doi.org/10.1111/epi.14058
Pawlikowska L, Tran MN, Achrol AS et al (2004) Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 35(10):2294–2300. https://doi.org/10.1161/01.STR.0000141932.44613.b1
Pawlikowska L, Poon KY, Achrol AS et al (2006) Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery 58(5):838–843; discussion 38–43. https://doi.org/10.1227/01.neu.0000209605.18358.e5
Rao X, Zhong J, Zhang S et al (2011) Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation 123(25):2964–2974. https://doi.org/10.1161/circulationaha.110.966408
Redekop G, TerBrugge K, Montanera W et al (1998) Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg 89(4):539–546. https://doi.org/10.3171/jns.1998.89.4.0539
Ring T, Spiegelhalter D (2007) Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. Kidney Int 72(11):1400–1402. https://doi.org/10.1038/sj.ki.5002488
Santoso A, Maulana R, Alzahra F, Maghfirah I, Putrinarita AD, Heriansyah T (2017) Associations between four types of single-nucleotide polymorphisms in PLA2G7 gene and clinical atherosclerosis: a meta-analysis. Am J Cardiovasc Dis 7(6):122–133
Schievink WI, Parisi JE, Piepgras DG, Michels VV (1997) Intracranial aneurysms in Marfan’s syndrome: an autopsy study. Neurosurgery 41(4):866–870 discussion 71
Schievink WI, Riedinger M, Maya MM (2005) Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet A 134a(1):45–48. https://doi.org/10.1002/ajmg.a.30475
Stafforini DM (2015) Plasma PAF-AH (PLA2G7): biochemical properties, association with LDLs and HDLs, and regulation of expression. Enzymes 38:71–93. https://doi.org/10.1016/bs.enz.2015.09.004
Stein KP, Wanke I, Forsting M et al (2015) Associated aneurysms in supratentorial arteriovenous malformations: impact of aneurysm size on haemorrhage. Cerebrovasc Dis 39(2):122–129. https://doi.org/10.1159/000369958
Theodotou CB, Snelling BM, Sur S et al (2017) Genetic associations of intracranial aneurysm formation and sub-arachnoid hemorrhage. Asian J Neurosurg 12(3):374–381. https://doi.org/10.4103/1793-5482.180972
Thomas JM, Surendran S, Abraham M et al (2016) Genetic and epigenetic mechanisms in the development of arteriovenous malformations in the brain. Clin Epigenetics 8:78. https://doi.org/10.1186/s13148-016-0248-8
Tsai TH, Chen YL, Lin HS, Liu CF, Chang HW, Lu CH, Chang WN, Chen SF, Wu CJ, Leu S, Ko SF, Yip HK (2012) Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke. J Atheroscler Thromb 19(6):523–531
Tyurin VA, Balasubramanian K, Winnica D et al (2014) Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic ‘eat-me’ signals: cleavage and inhibition of phagocytosis by Lp-PLA2. Cell Death Differ 21(5):825–835. https://doi.org/10.1038/cdd.2014.1
Wang Z, Zhao J, Sun J et al (2016) Sex-dichotomous effects of NOS1AP promoter DNA methylation on intracranial aneurysm and brain arteriovenous malformation. Neurosci Lett 621:47–53. https://doi.org/10.1016/j.neulet.2016.04.016
Yan J, Hitomi T, Takenaka K et al (2015) Genetic study of intracranial aneurysms. Stroke 46(3):620–626. https://doi.org/10.1161/strokeaha.114.007286
Yoshimura T, Ohshige A, Maeda T, Ito M, Okamura H (1999) Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. Maturitas 31(3):249–253
Yu L, Wang J, Wang S et al (2017) DNA Methylation Regulates Gene Expression in Intracranial Aneurysms. World Neurosurg 105:28–36. https://doi.org/10.1016/j.wneu.2017.04.064
Zhou J, Xu L, Huang RS et al (2013) Apolipoprotein A5 gene variants and the risk of coronary heart disease: a casecontrol study and metaanalysis. Mol Med Rep 8(4):1175–1182. https://doi.org/10.3892/mmr.2013.1642
Zhou S, Gao X, Sun J et al (2017) DNA methylation of the PDGFD gene promoter increases the risk for intracranial aneurysms and brain arteriovenous malformations. DNA Cell Biol 36(6):436–442. https://doi.org/10.1089/dna.2016.3499
Funding
This study was supported by grants from the Zhejiang Provincial Natural Science Foundation of China (LQ17H090002), Medicine and Health Science and Technology projects of Zhejiang province (2018KY665, 2017KY610), and Ningbo Health Branding Subject Fund (PPXK2018-04).
Author information
Authors and Affiliations
Contributions
Y.H., J.S. and Z.L. contributed conception and design of the study; X.W., S.N., S.Z. and X.G. organized the patients and performed the experiments; Y.L. and S.X. performed the statistical analysis; Y.L. wrote the first draft of the manuscript; Y.H., X.W. and Y.L. wrote sections of the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Strengths and Limitations of This Study
1. PLA2G7 methylation significantly associated with the risk of BAVMs in Han Chinese males.
2. PLA2G7 methylation was correlated with the risk of IAs in Han Chinese females.
3. PLA2G7 methylation was significantly lower in IAs than BAVMs in Han Chinese females.
4. PLA2G7 methylation significantly correlated with apoB and apoE levels in Han Chinese.
Rights and permissions
About this article
Cite this article
Liu, Y., Wu, X., Nie, S. et al. Methylation of Phospholipase A2 Group VII Gene Is Associated with Brain Arteriovenous Malformations in Han Chinese Populations. J Mol Neurosci 70, 1056–1063 (2020). https://doi.org/10.1007/s12031-020-01508-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01508-9